David Rosenbloom
Impact in
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
Papers in
-
- Venous Thromboembolism Diagnosis and Management 10
- Co-authors
- Gary E. RaskobRussell D. HullDavid GreenJack HirshHarry S. ShannonCharles E. CunninghamBonnie LendrumChristel A. Woodward
- Journals
- New England Journal of Medicine (4 papers)International Journal of Drug Policy (3 papers)Addictive Behaviors (3 papers)Alcoholism Clinical and Experimental Research (3 papers)Drug and Alcohol Dependence (3 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
David Rosenbloom
85 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Internal Medicine 1.8k
- Cardiology and Cardiovascular Medicine 1.4k
- Applied Psychology 272
- Emergency Medical Services 286
- Hematology 418
Countries citing papers authored by David Rosenbloom
This map shows the geographic impact of David Rosenbloom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rosenbloom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rosenbloom more than expected).
Fields of papers citing papers by David Rosenbloom
This network shows the impact of papers produced by David Rosenbloom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rosenbloom. The network helps show where David Rosenbloom may publish in the future.
Co-authors
The 25 scholars most cited alongside David Rosenbloom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 16 | |
| 3 | 2021 | 6 | |
| 4 | 2021 | 22 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 8 | |
| 7 | 2020 | 16 | |
| 8 | The n-of-1 Randomized Controlled Trial: Clinical Usefulness | 2020 | 3 |
| 9 | 2020 | 5 | |
| 10 | 2020 | 11 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 43 | |
| 13 | 2014 | 55 | |
| 14 | Preventing Underage Drinking: Using Getting to Outcomes with the SAMHSA Strategic Prevention Framework to Achieve Results. RAND Technical Report. | 2007 | 10 |
| 15 | 2006 | 99 | |
| 16 | 2002 | 5 | |
| 17 | Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. | 1997 | 83 |
| 18 | 1992 | 48 | |
| 19 | 1988 | 24 | |
| 20 | An intervention strategy for controlling costly care. | 1984 | 3 |
About David Rosenbloom
David Rosenbloom is a scholar working on Internal Medicine, Applied Psychology, Geriatrics and Gerontology, General Health Professions and Epidemiology, having authored 87 papers that have together received 4.2k indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (21 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Posttraumatic Stress Disorder Research (8 papers), Atrial Fibrillation Management and Outcomes (8 papers), Opioid Use Disorder Treatment (8 papers), Migration, Health and Trauma (7 papers), Smoking Behavior and Cessation (7 papers) and Alcohol Consumption and Health Effects (7 papers). The work is most often cited by research in Internal Medicine (1.8k citations), Cardiology and Cardiovascular Medicine (1.4k citations), Applied Psychology (272 citations), Emergency Medical Services (286 citations) and Hematology (418 citations). David Rosenbloom has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Gary E. Raskob, Russell D. Hull, David Green, Jack Hirsh, Harry S. Shannon, Charles E. Cunningham, Bonnie Lendrum, Christel A. Woodward, David L. Sackett and Judy Brown. Their work appears in journals such as New England Journal of Medicine, International Journal of Drug Policy, Addictive Behaviors, Alcoholism Clinical and Experimental Research and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.